What Is Airsupra?

Airsupra is a prescription metered-dose inhaler that combines two active ingredients — albuterol sulfate (a short-acting beta2-agonist, or SABA) and budesonide (an inhaled corticosteroid, or ICS) — in a single rescue inhaler. It is approved for adults 18 and older for as-needed treatment or prevention of bronchoconstriction in asthma and to reduce the risk of asthma exacerbations.

Airsupra is the first FDA-approved rescue inhaler to include an anti-inflammatory corticosteroid alongside a fast-acting bronchodilator. This means patients get immediate symptom relief and inflammation control in every rescue puff, rather than needing separate maintenance and rescue inhalers.

How does Airsupra work?

Airsupra works through two complementary mechanisms:

• Albuterol sulfate (SABA): Rapidly relaxes the smooth muscles surrounding the airways, opening them within minutes to relieve acute symptoms like wheezing, shortness of breath, and chest tightness.
• Budesonide (ICS): Reduces inflammation in the lungs over time. By delivering a corticosteroid with every rescue use, Airsupra helps address the underlying inflammation that triggers asthma attacks — not just the symptoms.

This dual-action approach aligns with updated asthma treatment guidelines that recommend anti-inflammatory reliever therapy over SABA-only rescue inhalers.

What doses are available for Airsupra?

• Metered-dose inhaler (MDI): 90 mcg albuterol / 80 mcg budesonide per actuation, 120 inhalations per canister (10.7g)

Only one strength is currently available. The standard dose is 2 puffs (inhalations) as needed, up to a maximum of 12 inhalations (6 doses) per 24 hours.

How hard is it to find Airsupra in stock?

Airsupra is not currently listed on the FDA or ASHP drug shortage databases. However, because it is a newer brand-name medication (FDA approved January 2023) with no generic available, many pharmacies may not routinely stock it. Availability issues are typically localized — your pharmacy may need to special-order it, which can take a few days. Insurance coverage gaps and the high retail price also contribute to limited stocking at some locations. Patients using Medfinder can quickly identify pharmacies that have Airsupra in stock near them.

Who Can Prescribe Airsupra?

Several types of healthcare providers can prescribe Airsupra:

• Pulmonologists — Lung specialists who often manage moderate-to-severe asthma
• Allergists/Immunologists — Specialists in allergic asthma and related conditions
• Primary Care Physicians and Family Medicine Doctors — Often the first point of contact for asthma management
• Internal Medicine Doctors — General internists who treat adult asthma
• Emergency Medicine Physicians — May prescribe Airsupra following an ER visit for an asthma exacerbation

Telehealth providers can also prescribe Airsupra, making it accessible for patients who have difficulty seeing a doctor in person.

Is Airsupra a controlled substance?

No, Airsupra is not a controlled substance. It is not scheduled by the DEA. You do not need special prescriptions or ID verification to fill it, and refills are straightforward. However, it does require a valid prescription from a licensed healthcare provider.

Common Side Effects of Airsupra

• Headache
• Cough
• Hoarseness or voice changes (dysphonia)
• Oral thrush (fungal infection in the mouth or throat)

Rinsing your mouth with water after each use can help reduce the risk of oral thrush. Contact your healthcare provider if side effects are bothersome or persistent.

Serious side effects (seek medical attention immediately):

• Paradoxical bronchospasm (sudden worsening of breathing)
• Rapid heartbeat or elevated blood pressure
• Severe allergic reactions (rash, facial swelling, difficulty breathing)
• Low potassium levels (hypokalemia)

Alternative Medications to Airsupra

• Albuterol (ProAir, Ventolin, Proventil): Traditional SABA rescue inhaler. Widely available as a generic and much less expensive, but does not include an anti-inflammatory component.
• Levalbuterol (Xopenex): A purified form of albuterol that may cause fewer side effects like jitteriness and rapid heartbeat. Available as nebulizer solution and MDI.
• Symbicort (Budesonide/Formoterol): An ICS/LABA combination maintenance inhaler that can also be used as a reliever (MART approach). Contains budesonide like Airsupra but paired with a long-acting beta-agonist.
• Breyna (Budesonide/Formoterol generic): A more affordable generic alternative to Symbicort for maintenance and reliever therapy.

Talk to your doctor about which option best fits your asthma management plan and budget.

Drug Interactions with Airsupra

• Beta-blockers: May block the bronchodilating effect of albuterol and can cause severe bronchospasm in asthma patients. Avoid concurrent use when possible.
• Strong CYP3A4 inhibitors (ketoconazole, ritonavir, itraconazole, clarithromycin): Can significantly increase budesonide levels in the body, raising the risk of corticosteroid side effects.
• MAO inhibitors and tricyclic antidepressants: May amplify cardiovascular effects of albuterol (increased heart rate and blood pressure).
• Non-potassium-sparing diuretics: May worsen low potassium levels when combined with albuterol.
• Digoxin: Low potassium caused by beta-agonists may increase the risk of digoxin toxicity.
• QTc-prolonging drugs: Combined use with albuterol may further increase the risk of abnormal heart rhythms.

Always inform your healthcare provider about all medications and supplements you take before starting Airsupra.

Final Thoughts on Airsupra

Airsupra represents a meaningful advancement in asthma rescue therapy — it's the first inhaler to combine fast-acting relief with anti-inflammatory protection in every puff. For patients who frequently reach for their rescue inhaler, this combination approach can help reduce asthma exacerbations while treating acute symptoms.

The main challenges are cost and availability. With no generic option and a retail price of $479–$737, Airsupra can be expensive without insurance. The SUPRA Savings Card can bring costs to $0 for commercially insured patients, and AstraZeneca Direct offers it at ~$249 for eligible patients. Because it's a newer medication, some pharmacies may not stock it — use Medfinder to quickly locate pharmacies with Airsupra in stock near you.